Screening & Brief Advice to Reduce Teen Substance Use

Status Completed

Clinical Trial Summary

The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).

We hypothesize that:

1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use;

2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use;

3. Among 12-18 year old well care patients who are at risk for riding with an impaired driver or driving while impaired, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing Riding/Driving risk behavior as measured by a standardized scale.

Clinical Trial Description

We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.

We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00227877
Study type	Interventional
Source	Boston Children’s Hospital
Contact
Status	Completed
Phase	N/A
Start date	December 2005
Completion date	February 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01655615` - Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?	N/A
Completed	`NCT01430741` - MISSION-Vet HUD-VASH Implementation Study	N/A
Active, not recruiting	`NCT02408952` - Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers	N/A
Completed	`NCT02520271` - Ostrobothnia Depression Study (ODS). A Naturalistic Follow-up Study on Depression and Related Substance Use Disorders	N/A
Completed	`NCT01976702` - Multi-Level HIV Prevention for Pregnant Drug Abusers	N/A
Active, not recruiting	`NCT05397925` - Effectiveness of a Training Program for Self-management of the Substance Addiction Consequences - a Study Protocol	N/A
Completed	`NCT01709552` - Brief Intervention for Substance Use and Partner Abuse Among Females in the ER	N/A
Recruiting	`NCT03585842` - French Validation of the Dual Diagnosis Screening Interview (F_DDSI)
Completed	`NCT03868930` - Multisite RCT of STEP-Home: A Transdiagnostic Skill-based Community Reintegration Workshop	N/A
Completed	`NCT01936857` - Buprenorphine to Improve HIV Care Engagement and Outcomes	Phase 4
Completed	`NCT02492893` - Yoga Intervention for Substance Use and ART Adherence in Community Reentry	N/A
Completed	`NCT01366716` - Contingency Management for Cocaine Dependence: Cash Versus Vouchers	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Screening and Brief Advice to Reduce Teen Substance Use

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms